ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
AcelRX Pharmaceuticals Inc

AcelRX Pharmaceuticals Inc (ACRX)

0,86
0,00
( 0,00% )
Mis à jour : 01:00:00

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,86
Prix Achat
0,861
Prix Vente
0,89
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
0,86
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
16 952 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,67
Bénéfice par action (BPA)
-1,09
Chiffre d'affairess
651k
Bénéfice net
-18,4M

À propos de AcelRX Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-

ACRX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACRX - Frequently Asked Questions (FAQ)

What is the current AcelRX Pharmaceuticals share price?
The current share price of AcelRX Pharmaceuticals is US$ 0,86
How many AcelRX Pharmaceuticals shares are in issue?
AcelRX Pharmaceuticals has 16 952 000 shares in issue
What is the market cap of AcelRX Pharmaceuticals?
The market capitalisation of AcelRX Pharmaceuticals is USD 14,58M
What is the 1 year trading range for AcelRX Pharmaceuticals share price?
AcelRX Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of AcelRX Pharmaceuticals?
The price to earnings ratio of AcelRX Pharmaceuticals is -0,67
What is the cash to sales ratio of AcelRX Pharmaceuticals?
The cash to sales ratio of AcelRX Pharmaceuticals is 19,01
What is the reporting currency for AcelRX Pharmaceuticals?
AcelRX Pharmaceuticals reports financial results in USD
What is the latest annual turnover for AcelRX Pharmaceuticals?
The latest annual turnover of AcelRX Pharmaceuticals is USD 651k
What is the latest annual profit for AcelRX Pharmaceuticals?
The latest annual profit of AcelRX Pharmaceuticals is USD -18,4M
What is the registered address of AcelRX Pharmaceuticals?
The registered address for AcelRX Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AcelRX Pharmaceuticals website address?
The website address for AcelRX Pharmaceuticals is talphera.com
Which industry sector does AcelRX Pharmaceuticals operate in?
AcelRX Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SLXNSilexion Therapeutics Corporation
US$ 1,14
(96,55%)
169,93M
RNAZTransCode Therapeutics Inc
US$ 11,79
(72,62%)
15,18M
RFACRF Acquisition Corporation
US$ 8,11
(62,20%)
5,77k
YIBOPlanet Image International Ltd
US$ 4,98
(61,69%)
47,84M
BACKIMAC Holdings Inc
US$ 1,1702
(41,16%)
52,14M
LPTXLeap Therapeutics Inc
US$ 0,6501
(-71,11%)
7,48M
STSSSharps Technology Inc
US$ 0,4454
(-69,49%)
11,19M
SABSSAB Biotherapeutics Inc
US$ 2,2568
(-48,24%)
905,32k
MGOLMGO Global Inc
US$ 0,1754
(-38,02%)
13,85M
INKTMiNK Therapeutics Inc
US$ 5,89
(-33,36%)
53,66k
HEPAHepion Pharmaceuticals Inc
US$ 0,2224
(34,79%)
229,36M
NVDANVIDIA Corporation
US$ 121,0425
(2,21%)
226,93M
SLXNSilexion Therapeutics Corporation
US$ 1,14
(96,55%)
169,93M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4766
(15,65%)
118,47M
TRIBTrinity Biotech PLC
US$ 1,06
(39,47%)
98,18M
Aucune Discussion Trouvée
Ajouter une Discussion